The Journal of Computer-Aided Molecular Design provides a forum for disseminating information on both the theory and the application of computer-based methods in the analysis and design of molecules. The scope of the journal encompasses papers which report new and original research and applications in the following areas:
theoretical chemistry
computational chemistry
computer and molecular graphics
molecular modeling
protein engineering
drug design
expert systems
general structure-property relationships
molecular dynamics
chemical database development and usage
Contributions on computer-aided molecular modeling studies in pharmaceutical, polymer, materials and surface sciences, as well as other molecular-based disciplines, are particularly welcome.

As of Volume 15, a number of issues per volume will be dedicated to Perspectives in Drug Discovery and Design and from time to time overviews will be included in `regular' JCAMD issues. Perspectives in Drug Discovery and Design was established to publish succinct overviews of current developments in the multidisciplinary area of drug discovery and design.

The intended scope of Perspectives in Drug Discovery and Design is greater than that of specialty journals and draws from fields both central and supplementary to those of drug discovery and design. In each thematic issue invited experts provide recent developments, highlight opportunities and indicate current limitations concerning the use of computers in drug discovery and design.

Articles are by invitation only from guest editors chosen for their overall expertise in the area, and are refereed in order to ensure the highest quality and breadth of coverage.

Journal of Computer-Aided Molecular Design

Senior Editor-in-Chief: 

Terry R. Stouch
Science For Solutions, LLC, Princeton NJ, USA
Editors-in-Chief:

Federico Gago
Dept. of Biomedical Sciences, University of Alcala, Madrid, Spain

Richard Lewis
Novartis Institutes for BioMedical Research, Basel, Switzerland

Editorial Board:

R. Abagyan, University of California, San Diego CA, USA; 
J. Blaney, Genentech, San Francisco CA, USA; 
H.-J. Böhm, Hoffmann-La Roche Ltd., Basel, Switzerland; 
R. Clark, Simulations Plus, Lancaster CA, USA; 
G. Cruciani, Università di Perugia, Italy; 
J.W. Essex, University of Southampton, UK; 
J. Gasteiger, Universität Erlangen-Nürnberg, Germany; 
M. Head, GlaxoSmithKline Pharmaceuticals, Collegeville PA, USA; 
C. Humblet, Eli Lilly and Company, Indianapolis IN, USA; 
A.N. Jain, University of California, San Francisco CA, USA; 
D. Joseph-McCarthy, EnBiotix, Inc. San Diego CA, USA; 
L.A. Kuhn, Michigan State University, East Lansing USA; 
A.E. Leach, Glaxo Medicines Research Centre, Stevenage, UK; 
F.J. Luque, University of Barcelona, Spain; 
A.E. Mark, University of Queensland, St. Lucia, QLD, Australia; 
G.R. Marshall, Washington University, St. Louis MO, USA; 
Y.C. Martin, Yvonne Martin Consulting, Waukegan IL, USA; 
D. Mobley, University of California, Irvine CA, USA; 
M. Murcko, Disruptive Biomedical LLC, Holliston MA, USA; 
T. I. Oprea, The University of New Mexico, Albuquerque NM, USA; 
A. Sali, University of California, San Francisco CA, USA; 
W. Sippl, Martin-Luther-Universität Halle-Wittenberg, Saale, Germany; 
M.J.E. Sternberg, Imperial Cancer Research Fund, London, UK; 
I.V. Tetko, Helmholtz Zentrum Muenchen, Neuherberg, Germany; 
A. Tropsha, University of North Carolina, Chapel Hill NC, USA;
Y.J. Tseng, National Taiwan University, Taiwan; 
J.G. Vinter, University Chemical Laboratories, Cambridge, UK; 
G. Vriend, EMBL, Heidelberg, Germany; 
R. Wade, European Media Laboratory, Heidelberg, Germany; 
P. Willett, University of Sheffield, UK.

Perspectives in Drug Discovery and Design

Editor-in-Chief: 
Yvonne C. Martin
Yvonne Martin Consulting, Waukegan IL, USA

Editorial Board:
R. Abagyan, University of California, San Diego CA, USA; 
R. Cramer, Certara, Santa Fe NM, USA; 
A. Jain, University of California, San Francisco CA, USA; 
P. Kenny, University of Sao Paulo, Sao Paulo, Brazil; 
G. Maggiora, University of Arizona, USA; 
U. Norinder, H. Lundbeck A/S, Copenhagen, Denmark; 
J. Overington, EMBL-EBI, Hinxton, UK; 
M. Rarey, University of Hamburg, Hamburg, Germany; 
T. Stouch, Science For Solutions, LLC, Princeton NJ, USA; 
A. Tropsha, University of North Carolina at Chapel Hill, USA; 
R. Wang, Shanghai Institute of Organic Chemistry, Shanghai, China; 
D. Winkler, Monash and La Trobe Universities, Victoria, Australia.